Addictions
No, drug prohibition is not ‘white supremacy’
From Break The Needle
British Columbia’s top doctor released a report arguing that the legalization of all drugs combats “racism” and “colonialism.” That’s historically illiterate.
The notion that drug prohibition is inherently racist has become exceedingly popular within the harm reduction world and, by extension, inside many public health institutions and graduate programs. Yet anyone with even a cursory knowledge of history can see that this is absurd. Societies from all across the world have long understood the dangers of addictive substances and supported efforts to criminalize them—so why is this being ignored?
Though the “prohibition is racist” movement usually flies under the public’s radar, it was thrust into the limelight earlier this month when B.C.’s top doctor, Bonnie Henry, released a report calling for the legalization of all drugs. Not only did Henry recommend that dangerous substances—including meth, cocaine and fentanyl—be sold in stores much like alcohol and cannabis, her team asserted that prohibitionist policies are “based on a history of racism, white supremacy, paternalism, colonialism, classism and human rights violations.”
One would hope such sweeping declarations would have been backed with fulsome arguments and historical references, but that didn’t happen here.
Instead, the report simply emphasized how Canada’s original drug laws, dating back to the late 19th and early 20th centuries, were motivated by racist animus against Chinese immigrants. As opium was popular among these immigrants, the drug was believed to pose a special moral threat to white society and was among the first substances to be harshly policed. This, in turn, gave the state a new legal tool to harass Chinese Canadians and, in some cases, deport them.
After briefly explaining this point, Henry’s report concluded that, “Over time, the moral panic associated with drug use expanded to target many more groups of people, including Indigenous people, Black people, women, people of colour, and people of lower socioeconomic status.” This extrapolation was presented as a self-evident fact, without any evidence or citations to explain or substantiate it.
Henry’s recommendations were immediately rejected by the provincial government and savagely ridiculed in the media. Yet the views articulated in her report, shocking as they may have been to many, were not actually exceptional. They only rehashed the dominant beliefs of the harm reduction world—beliefs have also, over the past decade or so, permeated deeply into Canada’s public health bureaucracies.
Henry’s report may be dead in the water, but the underlying ideas which animated it are still very much alive and will, in all likelihood, continue to influence Canadian policymakers within the cloistered hallways of the civil service. This is a shame, because it is difficult to overstate how strange these kinds of beliefs are.
To argue that drug prohibition is broadly based on a history of racism, mostly because it was misused for racist purposes a century ago, is kindergarten-level reasoning. There are ample examples of non-European societies, past and present, embracing criminalization. This is glaringly obvious and, in many cases, common knowledge.
Subscribe for free to get our latest news and analysis – or donate to our investigative journalism fund.
Non-Western drug prohibition throughout the ages
Perhaps one of the greatest examples of non-European drug prohibition is Sharia law, which has banned the consumption of mind-altering substances since the 7th century. One wonders how harm reduction activists can claim, with a straight face, that prohibition is rooted in “colonialism” and “white supremacy” when Islam’s religious and legal texts supported it centuries before global European empires emerged.
Since harm reduction scholars are so concerned about Chinese experiences, it would be instructive to look toward China itself, where prohibition is also popular.
In the late 18th century, the British began exporting large quantities of opium to the Qing Empire (China), which quickly fomented a wave of addiction and social disorder. Soon after, Qing officials embarked on a multi-decade campaign to criminalize the drug. “Opium is a poison, undermining our good customs and morality. Its use is prohibited by law,” wrote the Daoguang Emperor in an edict issued in 1810.
By the mid-19th century, the Qing worried that, without drastic action, China would be left bereft of money and productive men—so they banned all sales of opium and destroyed any supply of it they could find, including European wares. This angered the British, who profited handsomely off the opium trade, and led them to victoriously wage war against the Qing—not once, but twice—to forcibly stop prohibition.
Narcotics thus continued to flow through the veins of China’s body politic, wreaking havoc for generations. Since then, Chinese nationalists have bitterly remembered the Opium Wars as a colonial crime which marked the beginning of China’s “century of humiliation.”
The 98th Regiment of Foot at the attack on Chin-Kiang-Foo (Zhenjiang), 21 July 1842, resulting in the defeat of the Manchu government. Watercolour by military illustrator Richard Simkin (1840–1926).
This raises an important question: how exactly can anyone square this history with the ideological framework of the harm reduction movement? Were the Qing embodying some mystical form of white supremacy? Perhaps we should be grateful that the British sent their anti-racist warships to decolonize China’s drug laws.
Even today, the legacy of the Opium Wars continues to inform Chinese attitudes towards drugs—both within China itself (where strict prohibitionism is the norm) and in the diaspora.
In San Francisco, America’s petri dish for drug liberalization, it is Chinese-Americans who are leading a public backlash against progressive policies and calling for greater prohibition. Similarly, Chinese-Canadians were instrumental to Vancouver’s political pivot during the 2022 municipal elections, wherein the centrist ABC party swept the city council and the mayor’s office. Just this spring, Chinese-Canadian protestors in Richmond, the most ethnically Chinese city in North America , thwarted the launch of a new supervised consumption site, only to have a white progressive woman shout “Go back to Hong Kong” at them. No doubt another anti-racist activist.
When I interviewed almost a dozen Chinese-Canadian small business owners and workers in Vancouver’s historical Chinatown last summer, their support for prohibition was clear—and the legacy of the Opium Wars was invoked several times. Many other ethnic groups are processing similar historical traumas, and facing similar erasure. Do harm reduction activists forget, for example, that early European colonists devastated North American Indigenous communities by plying them with alcohol?
Indigenous leaders did not respond to that crisis by calling for more booze. On the contrary, they pushed for prohibition. Illustratively, when Treaties No. 6 and 7 were negotiated during the 1870s, Indigenous representatives asked for the “exclusion of fire water” from Saskatchewan, and that “no intoxicating liquor be allowed to be introduced or sold” on reserves. Even today, dozens of “dry” Indigenous reserves throughout Canada continue to ban alcohol and drugs to whatever extent they can.
When I interviewed over a dozen Indigenous elders and community members in Calgary last summer, their opposition to drug liberalization was clear—some went so far as to condemn decriminalization and “safer supply” programs as “pharmaceutical colonialism.” Ronnie Chickite, chief of the We Wai Kai Nation in British Columbia, told me this spring that his entire band council was “entirely against” decriminalization and that provincial officials had allegedly ignored them.
Building upon these interviews, two senior contacts in the Ontario government confirmed to me earlier this year that Indigenous leaders across the province seem to commonly hold prohibitionist beliefs. Who would have thought that Indigenous people could be such raging white supremacists?
Surveying the world today, it is clear that drug prohibition is actually strongest in non-European states—particularly East Asian and Middle Eastern ones—while liberalization is actually more popular in the West. It is telling that the harm reduction movement seems intent on ignoring this, or, alternatively, positioning non-white prohibitionism as a symptom of corrupting European influences. Both responses are, ironically, more than a little racist—how else can one describe the systematic erasure of non-European voices?
How is it that harm reduction advocates, who make such a theatre of their own “anti-racism,” cannot grasp that non-white communities have intellectual and cultural agency and do not simply let white people dictate their beliefs? In their obsessive disdain for European civilization, these advocates close their eyes to the rest of the world and inadvertently reproduce the same cultural narcissism that they ostensibly condemn—their calls for racial justice conceal a Eurocentric mindset sopping with paternalism.
How is this possible? How has this happened? A glimpse of an answer can be found in the “Acknowledgements” section of Henry’s report this month, where brief biographies of the report’s contributors were provided. Each contributor fixated on their ethnicity and, in many cases, proclaimed themselves as “third generation settlers” or “occupiers.” Unsurprisingly, almost everyone on the team was white. Though there were some Indigenous voices (who were seemingly relegated to working on exclusively Indigenous-related tasks, of course), not a single Asian, black or Middle-Eastern voice could be found.
The B.C. provincial health officer report’s contributors section:
So it seems that a bunch of white progressive bureaucrats produced a document that fixated on “colonialism” and “racism” while ignoring the actual beliefs of many, if not most, non-white communities. Nothing could encapsulate the harm reduction zeitgeist more perfectly: the privileging of empty gestures over real consultation, the self-indulgent self-flagellation of the white bourgeoisie, the patronizing assumption that minority communities have homogenous political beliefs that happen to align with progressive causes.
All of this would be comedic if lives weren’t at stake.
It should be clarified that there are many valid ways to criticize drug laws from a racial justice lens. Laws are just tools which we use to order society, and, like any tool, they can be abused—so it is fair to explore how some laws, in some contexts, have racist intentions or outcomes.
This is best illustrated by the wealth of scholarship criticizing American cannabis laws—in this case, critics have been able to concretely show that specific laws, in specific contexts, are being enforced unfairly and exacerbating inequities without producing justificatory social benefits.
Yet this mode of analysis, which focuses heavily on outcomes and concrete data, is an entirely different beast from the essentialist arguments recklessly flung around by the harm reduction movement. It makes sense to test measurable hypotheses about specific laws and their implementations. But to argue that drug prohibition is intrinsically “racist” is to succumb to ideological hallucination.
This essay originally appeared in The Hub and has been syndicated to Break The Needle through a co-publishing agreement.
Our content is always free – but if you want to help us commission more high-quality journalism, consider getting a voluntary paid subscription.
Addictions
BC Addictions Expert Questions Ties Between Safer Supply Advocates and For-Profit Companies
By Liam Hunt
Canada’s safer supply programs are “selling people down the river,” says a leading medical expert in British Columbia. Dr. Julian Somers, director of the Centre for Applied Research in Mental Health and Addiction at Simon Fraser University, says that despite the thin evidence in support of these experimental programs, the BC government has aggressively expanded them—and retaliated against dissenting researchers.
Somers also, controversially, raises questions about doctors and former health officials who appear to have gravitated toward businesses involved in these programs. He notes that these connections warrant closer scrutiny to ensure public policies remain free from undue industry influence.
Safer supply programs claim to reduce overdoses and deaths by distributing free addictive drugs—typically 8-milligram tablets of hydromorphone, an opioid as potent as heroin—to dissuade addicts from accessing riskier street substances. Yet, a growing number of doctors say these programs are deeply misguided—and widely defrauded.
Ultimately, Somers argues, safer supply is exacerbating the country’s addiction crisis.
Somers opposed safer supply at its inception and openly criticized its nationwide expansion in 2020. He believes these programs perpetuate drug use and societal disconnection and fail to encourage users to make the mental and social changes needed to beat addiction. Worse yet, the safer supply movement seems rife with double standards that devalue the lives of poorer drug users. While working professionals are provided generous supports that prioritize recovery, disadvantaged Canadians are given “ineffective yet profitable” interventions, such as safer supply, that “convey no expectation that stopping substance use or overcoming addiction is a desirable or important goal.”
To better understand addiction, Somers created the Inter-Ministry Evaluation Database (IMED) in 2004, which, for the first time in BC’s history, connected disparate information—i.e. hospitalizations, incarceration rates—about vulnerable populations.
Throughout its existence, health experts used IMED’s data to create dozens of research projects and papers. It allowed Somers to conduct a multi-million-dollar randomized control trial (the “Vancouver at Home” study) that showed that scattering vulnerable people into regular apartments throughout the city, rather than warehousing them in a few buildings, leads to better outcomes at no additional cost.
In early 2021, Somers presented recommendations drawn from his analysis of the IMED to several leading officials in the B.C. government. He says that these officials gave a frosty reception to his ideas, which prioritized employment, rehabilitation, and social integration over easy access to drugs. Shortly afterwards, the government ordered him to immediately and permanently delete the IMED’s ministerial data.
Somers describes the order as a “devastating act of retaliation” and says that losing access to the IMED effectively ended his career as a researcher. “My lab can no longer do the research we were doing,” he noted, adding that public funding now goes exclusively toward projects sympathetic to safer supply. The B.C. government has since denied that its order was politically motivated.
In early 2022, the government of Alberta commissioned a team of researchers, led by Somers, to investigate the evidence base behind safer supply. They found that there was no empirical proof that the experiment works, and that harm reduction researchers often advocated for safer supply within their studies even if their data did not support such recommendations.
Somers says that, after these findings were published, his team was subjected to a smear campaign that was partially organized by the British Columbia Centre on Substance Use (BCCSU), a powerful pro-safer supply research organization with close ties to the B.C. government. The BCCSU has been instrumental in the expansion of safer supply and has produced studies and protocols in support of it, sometimes at the behest of the provincial government.
Somers is also concerned about the connections between some of safer supply’s key proponents and for-profit drug companies.
He notes that the BCCSU’s founding executive director, Dr. Evan Wood, became Chief Medical Officer at Numinus Wellness, a publicly traded psychedelic company, in 2020. Similarly, Dr. Perry Kendall, who also served as a BCCSU executive director, went on to found Fair Price Pharma, a now-defunct for-profit company that specializes in providing pharmaceutical heroin to high-risk drug users, the following year.
While these connections are not necessarily unethical, they do raise important questions about whether there is enough industry regulation to minimize potential conflicts of interest, whether they be real or perceived.
The BCCSU was also recently criticized in an editorial by Canadian Affairs, which noted that the organization had received funding from companies such as Shoppers Drug Mart and Tilray (a cannabis company). The editorial argued that influential addiction research organizations should not receive drug industry funding and reported that Alberta founded its own counterpart to the BCCSU in August, known as the Canadian Centre of Recovery Excellence, which is legally prohibited from accepting such sponsorships.
Already, private interests are betting on the likely expansion of safer supply programs. For instance, Safe Supply Streaming Co., a publicly traded venture capital firm, has advertised to potential investors that B.C.’s safer supply system could create a multi-billion-dollar annual market.
Somers believes that Canada needs more transparency regarding how for-profit companies may be directly or indirectly influencing policy makers: “We need to know exactly, to the dollar, how much of [harm reduction researchers’] operating budget is flowing from industry sources.”
Editor’s note: This story is published in syndication with Break The Needle and Western Standard.
The Bureau is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.
Dr. Julian M. Somers is director of the Centre for Applied Research in Mental Health and Addiction at Simon Fraser University. He was Director of the UBC Psychology Clinic, and past president of the BC Psychological Association. Liam Hunt is a contributing author to the Centre For Responsible Drug Policy in partnership with the Macdonald-Laurier Institute.
Addictions
Ottawa “safer supply” clinic criticized by distraught mother
An Ottawa mother, who lost her daughter to addiction, is frustrated by Recovery Care’s failure to help her opioid-addicted son
Masha Krupp has already lost one child to an overdose and fears she could lose another.
In 2020, her 47-year-old daughter Larisa died from methadone toxicity just 12 days into an opioid addiction treatment program. The program is run by Recovery Care, an Ottawa-based harm reduction clinic with five locations across the city, which aims to stabilize drug users and eventually wean them off more potent drugs.
Krupp says she is skeptical about the effectiveness of the support and counseling services that Recovery Care claims to provide and believes the clinic was negligent in her daughter’s case.
On Oct. 22, the Ottawa mother testified before the House of Commons Standing Committee on Health, which is studying Canada’s opioid epidemic.
In her testimony, Krupp said her daughter was prescribed 30mg of methadone — 50 per cent more than the recommended induction dose — and was not given an opiate tolerance test before starting the program. Larisa received treatment at the Bells Corners Recovery Care location.
Krupp’s 30-year-old son, whom Canadian Affairs agreed not to name, has been a patient at Recovery Care’s ByWard Market location since 2021, where he receives a combination of methadone and hydromorphone, another prescription drug administered through the treatment program.
“Three years later, my son is still using fentanyl, crack cocaine and methadone, despite being with Dr. [Charles] Breau and with Recovery Care for over three years,” Krupp testified.
“About four weeks ago, I had to call 9-1-1 because he was overdosing,” Krupp told Canadian Affairs in an interview. “This is on the safer supply program … three years in, I should not be calling 9-1-1.”
Open diversion
Founded in 2018, Recovery Care is a partner in the Safer Supply Ottawa initiative. The initiative, which is led by Ottawa Public Health and managed by the nonprofit Pathways to Recovery, provides prescription pharmaceutical opioids to individuals who are at high risk of overdose.
Pathways to Recovery works with a network of service providers throughout the city — including Recovery Care — to administer safer supply.
Krupp says she supports the concept of safer supply, but believes it needs to be administered differently.
“You can’t give addicts 28 pills and say ‘Oh here you go,’” she said in her testimony. “They sell for three dollars a pop on the street,” she said, referring to the practice of some individuals selling their prescribed medications to fund purchases of more intense street drugs like heroin and fentanyl.
Krupp says she sees her son — and other patients of the program — openly divert their prescribed medications outside of the Recovery Care clinic in ByWard Market, where she parks to wait for him.
“[B]ecause there’s no treatment attached to [my son’s safer supply], it’s just the doctor gives him all these pills, he diverts them, gets the drugs he needs, and he’s still an addict,” Krupp said in her testimony.
Donna Sarrazin, chief executive of Recovery Care, told Canadian Affairs that Recovery Care has measures to address diversion, including security cameras and onsite security staff.
“Patients are educated at intake and ongoing that diversion is not permitted and that they could be removed from the program,” she said in an emailed statement.
“Recovery Care works to understand diversion and has continued to progress programs and actions to address the issues. Concerns expressed by the community and our teams are taken seriously,” she said.
Krupp says she has communicated her concerns about her son reselling his prescribed medications to his doctor, Dr. Charles Breau, both in-person and through faxed letters. “I never hear back from the doctor. Never,” she said.
Krupp also said in her testimony that police have spoken to her son about his diversion.
Breau did not respond to inquiries made to his clinical teams at Recovery Care or Montfort Hospital, a teaching hospital affiliated with the University of Ottawa.
Sarrazin said Breau is not able to comment on patient or family care.
In Krupp’s view, the safer supply program would be more successful if drug users were required to take prescribed medications under supervision.
“If he was receiving his hydromorphone under witnessed dosage and there was a treatment plan attached to it, I believe it would be successful,” she said.
Dr. Eileen de Villa, the City of Toronto’s medical officer of health, reinforced this point at the Oct. 22 Health Committee meeting. She said Toronto Public Health’s injectable opioid agonist therapy program — which combines observed administration with a treatment plan — has seen “incredible results.”
De Villa shared a case of a pregnant client who entered the program. “She went on to have a successful pregnancy, a healthy baby, has actually successfully completed the treatment, and is now housed and has even gained custody of her other children,” she said.
Subscribe for free to get BTN’s latest news and analysis, or donate to our journalism fund.
‘An affront to me’
Krupp also says Recovery Care fails to deliver on its promise of supporting patients’ mental health needs. Recovery Care’s website says its clinics offer “mental health programs which are essential to every treatment plan.”
Krupp and her son’s father have both requested a clear treatment plan and consistent counselling for their son. But he was started on safer supply after participating in only one virtual counselling session, she says.
She says Recovery Care has only one mental health counselor who services four of Recovery Care’s clinics. “If you’re getting $2-million-plus a year in funding, you should be able to staff each clinic with one on-site counselor five days a week,” she said.
Instead of personalized assistance, her son received “a sheaf of photocopies” offering generic services like Narcotics Anonymous and crisis helplines. “It’s almost an affront to me, as a taxpayer and a mother of an addict,” Krupp said.
Krupp says that, following her testimony to the parliamentary committee, Breau reached out to offer her son a mental health counseling session for the first time.
Sarrazin told Canadian Affairs that patients are encouraged to request counseling at any time. “Currently there is no wait list and appointments can be booked within 1 week,” she said in her emailed statement.
Class actions
Today, Krupp is considering launching a class-action lawsuit against Health Canada and the Government of Canada, challenging both the enactment of safer supply and the loosening of methadone dispensing requirements in 2017. She believes these changes contributed to her daughter’s death in 2020.
She is also considering joining an existing class-action lawsuit in B.C., which alleges Health Canada failed to monitor the distribution of drugs provided through safer supply programs.
The Pathways to Recovery initiative received $9.69-million in funding from Health Canada from July 2020 to March 2025. In June 2023, Health Canada allocated an additional $1.9 million to expand Ottawa’s safer supply program across five sites and improve access to practitioners, mental health support, housing and other services.
“I want to see that money being put to a recovery based treatment, not simply people going in and out and getting their medications and just creating this new sub-layer of addicts,” Krupp said.
This article was produced through the Breaking Needles Fellowship Program, which provided a grant to Canadian Affairs, a digital media outlet, to fund journalism exploring addiction and crime in Canada. Articles produced through the Fellowship are co-published by Break The Needle and Canadian Affairs.
Subscribe for free to get BTN’s latest news and analysis, or donate to our journalism fund.
-
ESG1 day ago
Can’t afford Rent? Groceries for your kids? Trudeau says suck it up and pay the tax!
-
Brownstone Institute2 days ago
The Most Devastating Report So Far
-
MAiD2 days ago
Over 40% of people euthanized in Ontario lived in poorest parts of the province: government data
-
COVID-192 days ago
Dr. McCullough praises RFK Jr., urges him to pull COVID shots from the market
-
Aristotle Foundation1 day ago
Toronto cancels history, again: The irony and injustice of renaming Yonge-Dundas Square to Sankofa Square
-
International24 hours ago
Euthanasia advocates use deception to affect public’s perception of assisted suicide
-
armed forces15 hours ago
Judge dismisses Canadian military personnel’s lawsuit against COVID shot mandate
-
Addictions1 day ago
BC Addictions Expert Questions Ties Between Safer Supply Advocates and For-Profit Companies